Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Surgical Infections|May 18, 2019
Fungal Isolates in Peritoneal Fluid Culture Do Not Impact Peri-Operative Outcomes of Peptic Ulcer PerforationJia Rui Kwan, Melvin Lim, Felicia Ng, et al.
Journal of Advanced Research|November 1, 2019
Human thrust in aquatic environment: The effect of post-activation potentiation on flutter kickFelicia Ng, Jia Wen Yam, Danny Lum, et al.
Cell Stem Cell|August 20, 2013
The epidermis comprises autonomous compartments maintained by distinct stem cell populationsMahalia E Page, Patrick Lombard, Felicia Ng, et al.
Journal of Agricultural and Food Chemistry|December 21, 2021
Profiling of Aroma-Active Compounds in Ylang-Ylang Essential Oils by Aroma Extract Dilution Analysis (AEDA) and Chemometric MethodsFelicia Ng, Aaron Thong, Nurhidayah Basri, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2019
Scaling up analogical innovation with crowds and AIAniket Kittur, Lixiu Yu, Tom Hope, et al.
Blood|March 12, 2008
PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineagesFelicia Ng, Shayne Boucher, Susie Koh, et al.
Cancer Research Communications|October 11, 2023
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell CarcinomaMaria Secrier, Lara McGrath, Felicia Ng, et al.
Molecular Cancer|December 2, 2025
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancerMingchao Xie, Miljenka Vuko, Shashank Saran, et al.
Frontiers in Immunology|October 8, 2024
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoringJulie Berthe, Pawan Poudel, Felix J Segerer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid TumorsLillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez, et al.
Pageof 2